These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 19056366)

  • 1. The two-fold aspect of the interplay of amyloidogenic proteins with lipid membranes.
    Relini A; Cavalleri O; Rolandi R; Gliozzi A
    Chem Phys Lipids; 2009 Mar; 158(1):1-9. PubMed ID: 19056366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amyloidogenic propensities and conformational properties of ProIAPP and IAPP in the presence of lipid bilayer membranes.
    Jha S; Sellin D; Seidel R; Winter R
    J Mol Biol; 2009 Jun; 389(5):907-20. PubMed ID: 19427320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atomic force microscopy reveals defects within mica supported lipid bilayers induced by the amyloidogenic human amylin peptide.
    Green JD; Kreplak L; Goldsbury C; Li Blatter X; Stolz M; Cooper GS; Seelig A; Kistler J; Aebi U
    J Mol Biol; 2004 Sep; 342(3):877-87. PubMed ID: 15342243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phospholipid catalysis of diabetic amyloid assembly.
    Knight JD; Miranker AD
    J Mol Biol; 2004 Aug; 341(5):1175-87. PubMed ID: 15321714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Size and morphology of toxic oligomers of amyloidogenic proteins: a case study of human stefin B.
    Ceru S; Kokalj SJ; Rabzelj S; Skarabot M; Gutierrez-Aguirre I; Kopitar-Jerala N; Anderluh G; Turk D; Turk V; Zerovnik E
    Amyloid; 2008 Sep; 15(3):147-59. PubMed ID: 18925453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of hIAPP with model raft membranes and pancreatic beta-cells: cytotoxicity of hIAPP oligomers.
    Weise K; Radovan D; Gohlke A; Opitz N; Winter R
    Chembiochem; 2010 Jun; 11(9):1280-90. PubMed ID: 20440729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biological membranes as protein aggregation matrices and targets of amyloid toxicity.
    Bucciantini M; Cecchi C
    Methods Mol Biol; 2010; 648():231-43. PubMed ID: 20700716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amyloid aggregation on lipid bilayers and its impact on membrane permeability.
    Friedman R; Pellarin R; Caflisch A
    J Mol Biol; 2009 Mar; 387(2):407-15. PubMed ID: 19133272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Membrane permeabilization by Islet Amyloid Polypeptide.
    Engel MF
    Chem Phys Lipids; 2009 Jul; 160(1):1-10. PubMed ID: 19501206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of lipid-protein interactions in amyloid-type protein fibril formation.
    Gorbenko GP; Kinnunen PK
    Chem Phys Lipids; 2006 Jun; 141(1-2):72-82. PubMed ID: 16569401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Islet amyloid polypeptide forms rigid lipid-protein amyloid fibrils on supported phospholipid bilayers.
    Domanov YA; Kinnunen PK
    J Mol Biol; 2008 Feb; 376(1):42-54. PubMed ID: 18155730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytotoxicity of insulin within its self-assembly and amyloidogenic pathways.
    Grudzielanek S; Velkova A; Shukla A; Smirnovas V; Tatarek-Nossol M; Rehage H; Kapurniotu A; Winter R
    J Mol Biol; 2007 Jul; 370(2):372-84. PubMed ID: 17521669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heparin inhibits membrane interactions and lipid-induced fibrillation of a prion amyloidogenic determinant.
    Bazar E; Sheynis T; Dorosz J; Jelinek R
    Chembiochem; 2011 Mar; 12(5):761-7. PubMed ID: 21337481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amyloid-forming proteins alter the local mechanical properties of lipid membranes.
    Burke KA; Yates EA; Legleiter J
    Biochemistry; 2013 Feb; 52(5):808-17. PubMed ID: 23331195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nano-scale imaging and dynamics of amylin-membrane interactions and its implication in type II diabetes mellitus.
    Cho WJ; Jena BP; Jeremic AM
    Methods Cell Biol; 2008; 90():267-86. PubMed ID: 19195555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Probing the interplay between amyloidogenic proteins and membranes using lipid monolayers and bilayers.
    Relini A; Marano N; Gliozzi A
    Adv Colloid Interface Sci; 2014 May; 207():81-92. PubMed ID: 24200086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polyglutamine aggregates impair lipid membrane integrity and enhance lipid membrane rigidity.
    Ho CS; Khadka NK; She F; Cai J; Pan J
    Biochim Biophys Acta; 2016 Apr; 1858(4):661-70. PubMed ID: 26806158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FRET studies of lipid-protein aggregates related to amyloid-like fibers.
    Coutinho A; Loura LM; Prieto M
    J Neurochem; 2011 Mar; 116(5):696-701. PubMed ID: 21214548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of human stefin B in the prefibrillar oligomeric form with membranes. Correlation with cellular toxicity.
    Anderluh G; Gutierrez-Aguirre I; Rabzelj S; Ceru S; Kopitar-Jerala N; Macek P; Turk V; Zerovnik E
    FEBS J; 2005 Jun; 272(12):3042-51. PubMed ID: 15955063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Formation of amyloid fibers triggered by phosphatidylserine-containing membranes.
    Zhao H; Tuominen EK; Kinnunen PK
    Biochemistry; 2004 Aug; 43(32):10302-7. PubMed ID: 15301528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.